Biohaven Ltd. (NYSE:BHVN) shares dropped 16.19% in after-hours trading to $9.06 on Wednesday after the company reported that its Phase 2 depression drug trial missed its primary endpoint.Check out the current price of BHVN stock here.The stock closed regular session at $10.81, up 2.95%, according... Read more
Benzinga - Dec 25
